Yuji Tanigaki

Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Hideaki Katori, M. Tsukuda, Izumi Mochimatu et al. · British Journal of Cancer · 2004 · 62 citations · Full text

The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: Correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma

Yuji Tanigaki, Yoji Nagashima, Yoshiaki Kitamura et al. · International Journal of Molecular Medicine · 2004 · 42 citations

Tongue Carcinoma, Angiogenesis, Tumor Innervation +14

Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas

Takahide Taguchi, Yuh Baba, Goshi Nishimura et al. · Oncology Reports · 2004 · 38 citations

Myxofibrosarcoma of the hypopharynx

Goshi Nishimura, Daisuke Sano, Miho Hanashi et al. · Auris Nasus Larynx · 2005 · 34 citations

Surgical Pathology, Histopathology, Pathogenesis +3

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

Mamoru Tsukuda, Yasukazu Mikami, Yuji Tanigaki et al. · International Journal of Clinical Oncology · 2004 · 24 citations

Neoadjuvant Therapy, Squamous Cell Carcinoma, Medicine +9